and 13 C 6 -glucose (3 g.l -1 ) as the sole source of nitrogen and carbon respectively and supplemented with 75 ug.ml -1 of kanamycin and 30 ug.ml -1 of chloramphenicol. The expression was induced with 0.2 mM isopropyl-beta-D-thiogalactoside (IPTG) and prolonged until the optical density at 600 nm reached 2.5 (overnight). The cells were harvested by centrifugation at 3 700 g at 25 °C for 5 min until the optical density of the supernatant was down to 0. Protein purification was done accordingly to the procedure previously described.
[ii]
The purification yielded lyophilized powders of C-terminal domain of Human centrin 2: 18 mg per litter of culture for the doubly labelled. Stock solutions of the protein were prepared in 20 mM TRIS, 400 mM NaCl and 10 mM CaCl 2 with a final concentration of 3 mM and stored at -80 °C in aliquots.
The P17-XPC peptide (95 % purity) with sequence Ac-NWKLLAKGLLIRERLKR-NH 2 was purchased from GeneCust (Dudelange, Luxembourg). All new batches were dissolved in water and lyophilized before use. Stock solutions were prepared in water with a final concentration of 6 mM and stored at -80 °C in aliquots.
Preparation of the complex solution
Equivolumes of the protein and the peptide were mixed resulting in a stoichiometric ratio of protein:peptide 1:2. The pH of the complex was adjusted to 4. The complex solution was kept at 4 °C for a maximum duration of one week. 
